{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT03719105",
            "orgStudyIdInfo": {
                "id": "NYMC 575"
            },
            "organization": {
                "fullName": "New York Medical College",
                "class": "OTHER"
            },
            "briefTitle": "Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/Lymphoma",
            "officialTitle": "Pilot Study Using Induction Chemo-immunotherapy Followed by Consolidation With Reduced Toxicity Conditioning and Allogenic Stem Cell Transplant in Advanced Stage Mature Non-anaplastic T-Cell or NK Lymphoma/Leukemia in Children, Adolescents and Young Adults; A NK/T-Cell Lymphoma/Leukemia Consortium Study",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "chemoimmunotherapy-and-allogeneic-stem-cell-transplant-for-nk-t-cell-leukemia-lymphoma"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-10",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2019-03-01",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-12-31",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-12-31",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2018-10-23",
            "studyFirstSubmitQcDate": "2018-10-23",
            "studyFirstPostDateStruct": {
                "date": "2018-10-25",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-10-24",
            "lastUpdatePostDateStruct": {
                "date": "2023-10-26",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Mitchell Cairo",
                "investigatorTitle": "Executive Vice-Chair",
                "investigatorAffiliation": "New York Medical College"
            },
            "leadSponsor": {
                "name": "New York Medical College",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "University of Alabama at Birmingham",
                    "class": "OTHER"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "Patients are in 2 cohorts:\n\nCohort 1: dexamethasone, methotrexate, ifosfamide, pegaspargase, and etoposide (modified SMILE) chemotherapy regimen alone and pembrolizumab in children, adolescents, and young adults with advanced stage NK lymphoma and leukemia Cohort 2: combining pralatrexate (PRX) (Cycles 1, 2, 4, 6) and brentuximab vedotin (BV) (Cycles 3, 5) to cyclophosphamide, doxorubicin, and prednisone in children, adolescent, and young adults with advanced peripheral T-cell lymphoma (non-anaplastic large cell lymphoma or non-NK lymphoma/leukemia) .\n\nBoth groups proceed to allogeneic stem cell transplant with disease response."
        },
        "conditionsModule": {
            "conditions": [
                "NK-Cell Lymphoma",
                "NK-Cell Leukemia",
                "Peripheral T Cell Lymphoma"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "EARLY_PHASE1"
            ],
            "designInfo": {
                "allocation": "NON_RANDOMIZED",
                "interventionModel": "PARALLEL",
                "interventionModelDescription": "Cohort 1 and 2 will be based on initial diagnosis.",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 40,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Cohort 1",
                    "type": "EXPERIMENTAL",
                    "description": "Patients with aggressive NK cell leukemia or stage III or IV extranodal NK/T-cell lymphoma, nasal type.\n\nChemotherapy Regimen:\n\nmSMILE: Methotrexate Day 1, Ifosfamide Days 2-4, Dexamethasone Days 2-4, Etoposide Days 2-4, calaspargase pegol Day 8. For patients in CR and no available allogeneic SCT can receive up to 2 additional cycles of mSMILE.\n\nPembrolizumab: For patients in PR/MR/NR/PD after 2 cycles of mSMILE.\n\nAllogeneic Stem Cell Transplant if donor available and not in PD.",
                    "interventionNames": [
                        "Drug: Methotrexate",
                        "Drug: Ifosfamide",
                        "Drug: Dexamethasone",
                        "Drug: Etoposide",
                        "Drug: calaspargase pegol"
                    ]
                },
                {
                    "label": "Cohort 2",
                    "type": "EXPERIMENTAL",
                    "description": "Patients with stage III or IV peripheral T-cell lymphoma-NOS, angioimmunoblastic T-cell lymphoma, hepatosplenic T-cell lymphoma, or enteropathy-associated T-cell lymphoma (other histologies will be considered after case-by-case discussion with Study Chairs and Executive Vice-Chairs).\n\nChemotherapy Regimen:\n\nCycle 1 \\& 2: Pralatrexate Days 1, 8, and 15, cyclophosphamide Day 1, DOXOrubicin Day 1, predniSONE days 1-5 Cycle 3 \\& 5: Brentuximab vedotin Day 1, cyclophosphamide Day 1, DOXOrubicin Day 1, predniSONE days 1-5 Cycle 4 \\& 6: Pralatrexate Days 1, 8, and 15, cyclophosphamide Day 1, DOXOrubicin Day 1, predniSONE days 1-5 Allogeneic Stem Cell Transplant if donor available and not in PD.",
                    "interventionNames": [
                        "Drug: pralatraxate,",
                        "Drug: cyclophosphamide",
                        "Drug: Doxorubicin",
                        "Drug: Prednisone",
                        "Drug: Brentuximab Vedotin"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Methotrexate",
                    "description": "Patients will receive methotrexate as part of chemoimmunotherapy regemin followed by allogeneic stem cell transplant.",
                    "armGroupLabels": [
                        "Cohort 1"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "pralatraxate,",
                    "description": "Patients will receive pralaxtraxate as part of chemoimmunotherapy regimen followed by allogeneic stem cell transplant.",
                    "armGroupLabels": [
                        "Cohort 2"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Ifosfamide",
                    "description": "Patients will receive Ifsofamide as part of chemoimmunotherapy regimen followed by allogeneic stem cell transplant.",
                    "armGroupLabels": [
                        "Cohort 1"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Dexamethasone",
                    "description": "Patients will receive dexamethasone as part of chemoimmunotherapy regimen followed by allogeneic stem cell transplant.",
                    "armGroupLabels": [
                        "Cohort 1"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Etoposide",
                    "description": "Patients will receive etoposide as part of chemoimmunotherapy regimen followed by allogeneic stem cell transplant.",
                    "armGroupLabels": [
                        "Cohort 1"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "calaspargase pegol",
                    "description": "Patients will receive pegaspargase as part of chemoimmunotherapy regimen followed by allogeneic stem cell transplant.",
                    "armGroupLabels": [
                        "Cohort 1"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "cyclophosphamide",
                    "description": "Patients will receive cyclophosphamide as part of chemoimmunotherapy regimen followed by allogeneic stem cell transplant.",
                    "armGroupLabels": [
                        "Cohort 2"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Doxorubicin",
                    "description": "Patients will receive doxorubicin as part of chemoimmunotherapy regimen followed by allogeneic stem cell transplant.",
                    "armGroupLabels": [
                        "Cohort 2"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Prednisone",
                    "description": "Patients will receive prednisone as part of chemoimmunotherapy regimen followed by allogeneic stem cell transplant.",
                    "armGroupLabels": [
                        "Cohort 2"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Brentuximab Vedotin",
                    "description": "Patients will receive brentuximab vedotin as part of chemoimmunotherapy regimen followed by allogeneic stem cell transplant.",
                    "armGroupLabels": [
                        "Cohort 2"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "overall response rate",
                    "description": "to assess overall response rate following chemoimmunotherapy induction therapy",
                    "timeFrame": "1 year"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "event free survival",
                    "description": "to determine the event free survival after induction chemoimmunotherapy and allogeneic stem cell transplantation",
                    "timeFrame": "2 year"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients must weigh at least 10 kilograms at the time of the study enrollment.\n* Diagnosis\n\nNewly diagnosed patients with histologically proven mature T- and NK- cell neoplasms:\n\nCOHORT 1\n\n* Aggressive NK cell leukemia (ICD-O code 9948/3)\n* Extranodal NK/T-cell lymphoma, nasal type (ICD-O code 9719/3) COHORT 2\n* Enteropathy-associated T-cell lymphoma (ICD-O code 9717/3)\n* Hepatosplenic T-cell lymphoma (ICD-O code 9716/3)\n* Peripheral T-cell lymphoma, non-otherwise specified (ICD-O code 9702/3)\n* Angioimmunoblastic T-cell lymphoma (ICD-O code 9705/3)\n* Other mature T- and NK-cell neoplasm histologies will considered after case-by-case discussion with Study Chairs and executive Vice-Chair Patients with lymphoma must have stage III or IV disease (See Appendix III for Staging).\n\n  * Organ Function Requirements\n\nAdequate liver function defined as:\n\n* Total bilirubin \u2264 1.5 x upper limit of normal (ULN) for age.\n* ALT (SGPT) \\< 3 x ULN for age.\n\nAdequate cardiac function defined as:\n\n* Shortening fraction of \u2265 27% by echocardiogram, or\n* Ejection fraction of \u2265 50% by radionuclide angiogram.\n\nAdequate pulmonary function defined as:\n\n\u2022 Patients with a history of pulmonary dysfunction must have no evidence of dyspnea at rest, no exercise intolerance due to pulmonary insufficiency, and a pulse oximetry \\> 92% while breathing room air unless current dysfunction is due to the lymphoma, in which case the patient is eligible.\n\nExclusion Criteria:\n\n* Alk+ or Alk- Anaplastic Large Cell Lymphoma (ALCL)\n* Patients with active CNS disease.\n* Patients with stage I or stage II disease (See Appendix III for Staging).\n* Patients who have received any prior cytotoxic chemotherapy for the current diagnosis of NHL.\n* Previous steroid treatment and/or radiation treatment are not allowed unless they are used for emergency management. Patients who have received emergency irradiation and/or steroid therapy will be eligible only if started on protocol therapy not more than one week from the start of radiotherapy or steroids.\n* Female patients who are pregnant. Pregnancy tests must be obtained in girls who are post menarchal.\n* Lactating females, unless they have agreed not to breastfeed their infants.\n* Patients with Down syndrome.\n* Patients taking CYP3A4 substrates with narrow therapeutic indices. Patients (COHORT 2 ONLY) chronically receiving medications known to be metabolized by CYP3A4 and with narrow therapeutic indices (See Appendix V). The topical use of these medications (if applicable) is allowed.\n* Patients taking CYP3A4 inhibitors. Patients (COHORT 2 ONLY) chronically receiving drugs that are known potent CYP3A4 inhibitors within 7 days prior to study enrollment (See Appendix V). The topical use of these medications (if applicable) is allowed.\n* Patients taking CYP3A4 inducers. Patients (COHORT 2 ONLY) chronically receiving drugs that are known potent CYP3A4 inducers within 12 days prior to study enrollment (See Appendix V).",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "1 Year",
            "maximumAge": "31 Years",
            "stdAges": [
                "CHILD",
                "ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Ana Xavier",
                    "role": "CONTACT",
                    "phone": "(205) 638-6763",
                    "email": "axavier@peds.uab.edu"
                },
                {
                    "name": "Lauren Harrison",
                    "role": "CONTACT",
                    "phone": "6172857844",
                    "email": "lauren_harrison@nymc.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Mitchell Cairo, MD",
                    "affiliation": "New York Medical College",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "University of Alabama",
                    "status": "RECRUITING",
                    "city": "Birmingham",
                    "state": "Alabama",
                    "zip": "35223",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Ana Xavier, MD",
                            "role": "CONTACT",
                            "email": "axavier@peds.uab.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.52066,
                        "lon": -86.80249
                    }
                },
                {
                    "facility": "Children's Hospital Orange County",
                    "status": "RECRUITING",
                    "city": "Orange",
                    "state": "California",
                    "zip": "92968",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Carol Lin, MD",
                            "role": "CONTACT",
                            "email": "clin@choc.org"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.78779,
                        "lon": -117.85311
                    }
                },
                {
                    "facility": "University of California San Francisco",
                    "status": "RECRUITING",
                    "city": "San Francisco",
                    "state": "California",
                    "zip": "94143",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "MIchelle Hermiston, MD",
                            "role": "CONTACT",
                            "email": "michelle.hermiston@ucsf.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.77493,
                        "lon": -122.41942
                    }
                },
                {
                    "facility": "Helen De Vos",
                    "status": "RECRUITING",
                    "city": "Grand Rapids",
                    "state": "Michigan",
                    "zip": "49503",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Troy Quigg, MD",
                            "role": "CONTACT",
                            "email": "troy.quigg@spectrumhealth.org"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.96336,
                        "lon": -85.66809
                    }
                },
                {
                    "facility": "New York Medical College",
                    "status": "RECRUITING",
                    "city": "Valhalla",
                    "state": "New York",
                    "zip": "10595",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Mitchell Cairo, MD",
                            "role": "CONTACT",
                            "phone": "914-594-3650",
                            "email": "mitchell_cairo@nymc.edu"
                        },
                        {
                            "name": "Lauren Harrison, MSN",
                            "role": "CONTACT",
                            "phone": "617-285-7844",
                            "email": "lauren_harrison@nymc.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.07482,
                        "lon": -73.77513
                    }
                },
                {
                    "facility": "Nationwide Children's Hospital",
                    "status": "RECRUITING",
                    "city": "Columbus",
                    "state": "Ohio",
                    "zip": "43205",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Anthony Audino, MD",
                            "role": "CONTACT",
                            "email": "Anthony.Audino@nationwidechildrens.org"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.96118,
                        "lon": -82.99879
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000008223",
                    "term": "Lymphoma"
                },
                {
                    "id": "D000007938",
                    "term": "Leukemia"
                },
                {
                    "id": "D000016399",
                    "term": "Lymphoma, T-Cell"
                },
                {
                    "id": "D000016411",
                    "term": "Lymphoma, T-Cell, Peripheral"
                }
            ],
            "ancestors": [
                {
                    "id": "D000009370",
                    "term": "Neoplasms by Histologic Type"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000008232",
                    "term": "Lymphoproliferative Disorders"
                },
                {
                    "id": "D000008206",
                    "term": "Lymphatic Diseases"
                },
                {
                    "id": "D000007160",
                    "term": "Immunoproliferative Disorders"
                },
                {
                    "id": "D000007154",
                    "term": "Immune System Diseases"
                },
                {
                    "id": "D000006402",
                    "term": "Hematologic Diseases"
                },
                {
                    "id": "D000008228",
                    "term": "Lymphoma, Non-Hodgkin"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M11220",
                    "name": "Lymphoma",
                    "asFound": "Lymphoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10945",
                    "name": "Leukemia",
                    "asFound": "Leukemia",
                    "relevance": "HIGH"
                },
                {
                    "id": "M18829",
                    "name": "Lymphoma, T-Cell",
                    "asFound": "T-cell Lymphoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M18833",
                    "name": "Lymphoma, T-Cell, Peripheral",
                    "asFound": "T-cell Lymphoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M18119",
                    "name": "Leukemia, T-Cell",
                    "relevance": "LOW"
                },
                {
                    "id": "M12315",
                    "name": "Neoplasms by Histologic Type",
                    "relevance": "LOW"
                },
                {
                    "id": "M11225",
                    "name": "Lymphoproliferative Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M11203",
                    "name": "Lymphatic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M10206",
                    "name": "Immunoproliferative Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M10200",
                    "name": "Immune System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M9490",
                    "name": "Hematologic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M11222",
                    "name": "Lymphoma, Non-Hodgkin",
                    "relevance": "LOW"
                },
                {
                    "id": "T3543",
                    "name": "Lymphosarcoma",
                    "asFound": "Lymphoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "T4496",
                    "name": "Peripheral T-cell Lymphoma",
                    "asFound": "Peripheral T-cell Lymphoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "T2165",
                    "name": "Extranodal Nasal NK/T Cell Lymphoma",
                    "relevance": "LOW"
                },
                {
                    "id": "T238",
                    "name": "Aggressive NK Cell Leukemia",
                    "asFound": "NK-cell Leukemia",
                    "relevance": "HIGH"
                },
                {
                    "id": "T3393",
                    "name": "Leukemia, T-cell, Chronic",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BC15",
                    "name": "Blood and Lymph Conditions"
                },
                {
                    "abbrev": "BC20",
                    "name": "Immune System Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000003907",
                    "term": "Dexamethasone"
                },
                {
                    "id": "D000011241",
                    "term": "Prednisone"
                },
                {
                    "id": "D000003520",
                    "term": "Cyclophosphamide"
                },
                {
                    "id": "D000007069",
                    "term": "Ifosfamide"
                },
                {
                    "id": "D000004317",
                    "term": "Doxorubicin"
                },
                {
                    "id": "D000008727",
                    "term": "Methotrexate"
                },
                {
                    "id": "D000005047",
                    "term": "Etoposide"
                },
                {
                    "id": "D000079963",
                    "term": "Brentuximab Vedotin"
                }
            ],
            "ancestors": [
                {
                    "id": "D000007166",
                    "term": "Immunosuppressive Agents"
                },
                {
                    "id": "D000007155",
                    "term": "Immunologic Factors"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000018501",
                    "term": "Antirheumatic Agents"
                },
                {
                    "id": "D000018906",
                    "term": "Antineoplastic Agents, Alkylating"
                },
                {
                    "id": "D000000477",
                    "term": "Alkylating Agents"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000000970",
                    "term": "Antineoplastic Agents"
                },
                {
                    "id": "D000019653",
                    "term": "Myeloablative Agonists"
                },
                {
                    "id": "D000000893",
                    "term": "Anti-Inflammatory Agents"
                },
                {
                    "id": "D000000932",
                    "term": "Antiemetics"
                },
                {
                    "id": "D000001337",
                    "term": "Autonomic Agents"
                },
                {
                    "id": "D000018373",
                    "term": "Peripheral Nervous System Agents"
                },
                {
                    "id": "D000005765",
                    "term": "Gastrointestinal Agents"
                },
                {
                    "id": "D000005938",
                    "term": "Glucocorticoids"
                },
                {
                    "id": "D000006728",
                    "term": "Hormones"
                },
                {
                    "id": "D000006730",
                    "term": "Hormones, Hormone Substitutes, and Hormone Antagonists"
                },
                {
                    "id": "D000018931",
                    "term": "Antineoplastic Agents, Hormonal"
                },
                {
                    "id": "D000000903",
                    "term": "Antibiotics, Antineoplastic"
                },
                {
                    "id": "D000059005",
                    "term": "Topoisomerase II Inhibitors"
                },
                {
                    "id": "D000059003",
                    "term": "Topoisomerase Inhibitors"
                },
                {
                    "id": "D000004791",
                    "term": "Enzyme Inhibitors"
                },
                {
                    "id": "D000000020",
                    "term": "Abortifacient Agents, Nonsteroidal"
                },
                {
                    "id": "D000000019",
                    "term": "Abortifacient Agents"
                },
                {
                    "id": "D000012102",
                    "term": "Reproductive Control Agents"
                },
                {
                    "id": "D000000964",
                    "term": "Antimetabolites, Antineoplastic"
                },
                {
                    "id": "D000000963",
                    "term": "Antimetabolites"
                },
                {
                    "id": "D000003879",
                    "term": "Dermatologic Agents"
                },
                {
                    "id": "D000005493",
                    "term": "Folic Acid Antagonists"
                },
                {
                    "id": "D000019384",
                    "term": "Nucleic Acid Synthesis Inhibitors"
                },
                {
                    "id": "D000000972",
                    "term": "Antineoplastic Agents, Phytogenic"
                },
                {
                    "id": "D000074322",
                    "term": "Antineoplastic Agents, Immunological"
                },
                {
                    "id": "D000000922",
                    "term": "Immunotoxins"
                },
                {
                    "id": "D000018796",
                    "term": "Immunoconjugates"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M6727",
                    "name": "Cyclophosphamide",
                    "asFound": "Effect of",
                    "relevance": "HIGH"
                },
                {
                    "id": "M8191",
                    "name": "Etoposide",
                    "asFound": "Complete",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10117",
                    "name": "Ifosfamide",
                    "asFound": "Ventricular",
                    "relevance": "HIGH"
                },
                {
                    "id": "M7492",
                    "name": "Doxorubicin",
                    "asFound": "Cognitive",
                    "relevance": "HIGH"
                },
                {
                    "id": "M7102",
                    "name": "Dexamethasone",
                    "asFound": "High",
                    "relevance": "HIGH"
                },
                {
                    "id": "M235549",
                    "name": "Dexamethasone acetate",
                    "relevance": "LOW"
                },
                {
                    "id": "M349416",
                    "name": "Pembrolizumab",
                    "relevance": "LOW"
                },
                {
                    "id": "M2853",
                    "name": "Immunomodulating Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M251156",
                    "name": "Pegaspargase",
                    "relevance": "LOW"
                },
                {
                    "id": "M14121",
                    "name": "Prednisone",
                    "asFound": "Prospective",
                    "relevance": "HIGH"
                },
                {
                    "id": "M11703",
                    "name": "Methotrexate",
                    "asFound": "Under",
                    "relevance": "HIGH"
                },
                {
                    "id": "M227339",
                    "name": "Liposomal doxorubicin",
                    "relevance": "LOW"
                },
                {
                    "id": "M341643",
                    "name": "Etoposide phosphate",
                    "relevance": "LOW"
                },
                {
                    "id": "M2088",
                    "name": "Brentuximab Vedotin",
                    "asFound": "Polymorphism",
                    "relevance": "HIGH"
                },
                {
                    "id": "M230811",
                    "name": "Isophosphamide mustard",
                    "relevance": "LOW"
                },
                {
                    "id": "M10212",
                    "name": "Immunosuppressive Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M10201",
                    "name": "Immunologic Factors",
                    "relevance": "LOW"
                },
                {
                    "id": "M20604",
                    "name": "Antirheumatic Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M20942",
                    "name": "Antineoplastic Agents, Alkylating",
                    "relevance": "LOW"
                },
                {
                    "id": "M3820",
                    "name": "Alkylating Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4217",
                    "name": "Anti-Inflammatory Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4251",
                    "name": "Antiemetics",
                    "relevance": "LOW"
                },
                {
                    "id": "M8881",
                    "name": "Gastrointestinal Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M9047",
                    "name": "Glucocorticoids",
                    "relevance": "LOW"
                },
                {
                    "id": "M9789",
                    "name": "Hormones",
                    "relevance": "LOW"
                },
                {
                    "id": "M9788",
                    "name": "Hormone Antagonists",
                    "relevance": "LOW"
                },
                {
                    "id": "M20966",
                    "name": "Antineoplastic Agents, Hormonal",
                    "relevance": "LOW"
                },
                {
                    "id": "M4222",
                    "name": "Anti-Bacterial Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4224",
                    "name": "Antibiotics, Antitubercular",
                    "relevance": "LOW"
                },
                {
                    "id": "M29348",
                    "name": "Topoisomerase Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M7951",
                    "name": "Enzyme Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M4281",
                    "name": "Antimetabolites",
                    "relevance": "LOW"
                },
                {
                    "id": "M7074",
                    "name": "Dermatologic Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M17546",
                    "name": "Vitamin B Complex",
                    "relevance": "LOW"
                },
                {
                    "id": "M8618",
                    "name": "Folic Acid",
                    "relevance": "LOW"
                },
                {
                    "id": "M8619",
                    "name": "Folic Acid Antagonists",
                    "relevance": "LOW"
                },
                {
                    "id": "M1346",
                    "name": "Antineoplastic Agents, Immunological",
                    "relevance": "LOW"
                },
                {
                    "id": "M4241",
                    "name": "Immunotoxins",
                    "relevance": "LOW"
                },
                {
                    "id": "M20855",
                    "name": "Immunoconjugates",
                    "relevance": "LOW"
                },
                {
                    "id": "T446",
                    "name": "Folic Acid",
                    "relevance": "LOW"
                },
                {
                    "id": "T447",
                    "name": "Folinic Acid",
                    "relevance": "LOW"
                },
                {
                    "id": "T448",
                    "name": "Folate",
                    "relevance": "LOW"
                },
                {
                    "id": "T475",
                    "name": "Vitamin B9",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "ANeo",
                    "name": "Antineoplastic Agents"
                },
                {
                    "abbrev": "ARhu",
                    "name": "Antirheumatic Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "Infl",
                    "name": "Anti-Inflammatory Agents"
                },
                {
                    "abbrev": "AnEm",
                    "name": "Antiemetics"
                },
                {
                    "abbrev": "Gast",
                    "name": "Gastrointestinal Agents"
                },
                {
                    "abbrev": "Derm",
                    "name": "Dermatologic Agents"
                },
                {
                    "abbrev": "Repr",
                    "name": "Reproductive Control Agents"
                },
                {
                    "abbrev": "Infe",
                    "name": "Anti-Infective Agents"
                },
                {
                    "abbrev": "Micro",
                    "name": "Micronutrients"
                },
                {
                    "abbrev": "Hemat",
                    "name": "Hematinics"
                },
                {
                    "abbrev": "Vi",
                    "name": "Vitamins"
                }
            ]
        }
    },
    "hasResults": false
}